GKB Ophthalmics Ltd

GKB Ophthalmics Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

GKB Ophthalmics Ltd

₹ 77.4 -1.66%
28 Aug - close price
gkb.net BSE: 533212
About

Incorporated in 1981, GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and Plastic

Key Points

Product Profile:[1]
a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor
b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
c) Progressive: 1.498 CR-39, 1.50 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
d) Aspheric: 1.498 CR-39

Website BSE
  • Market Cap ₹ 39.0 Cr.
  • Current Price ₹ 77.4
  • High / Low ₹ 124 / 59.0
  • Stock P/E
  • Book Value ₹ 103
  • Dividend Yield 0.00 %
  • ROCE -6.00 %
  • ROE -12.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.75 times its book value
  • Debtor days have improved from 112 to 85.4 days.
  • Company's working capital requirements have reduced from 103 days to 77.6 days

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of -5.60% over last 3 years.
  • Contingent liabilities of Rs.17.9 Cr.
  • Promoter holding has decreased over last 3 years: -8.67%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
17.84 18.56 19.11 19.96 22.26 20.40 24.04 21.56 26.02 26.14 25.80 31.02 32.31
15.24 17.02 19.18 20.35 20.91 20.69 24.66 21.56 24.98 26.20 26.74 33.88 31.51
Operating Profit 2.60 1.54 -0.07 -0.39 1.35 -0.29 -0.62 0.00 1.04 -0.06 -0.94 -2.86 0.80
OPM % 14.57% 8.30% -0.37% -1.95% 6.06% -1.42% -2.58% 0.00% 4.00% -0.23% -3.64% -9.22% 2.48%
0.35 0.37 -0.03 0.23 0.35 0.31 0.35 0.60 0.28 0.28 0.48 0.35 0.21
Interest 0.38 0.46 0.40 0.43 0.43 0.46 0.44 0.57 0.55 0.55 0.63 0.63 0.77
Depreciation 0.42 0.39 0.40 1.63 0.72 0.73 0.73 0.72 0.76 0.77 0.77 0.80 0.80
Profit before tax 2.15 1.06 -0.90 -2.22 0.55 -1.17 -1.44 -0.69 0.01 -1.10 -1.86 -3.94 -0.56
Tax % -0.93% -1.89% 18.89% -4.95% 0.00% 0.00% 0.00% 30.43% 600.00% 5.45% 2.69% 4.82% 14.29%
2.21 1.11 -1.11 -2.08 0.54 -1.19 -1.44 -0.89 0.11 -1.15 -1.91 -4.13 -0.64
EPS in Rs 3.85 1.69 -2.04 -3.81 1.03 -2.32 -2.48 -1.81 -0.50 -2.42 -4.03 -7.04 -2.02
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
41 35 44 76 78 57 59 57 71 75 88 109 115
34 34 44 75 77 56 56 55 66 72 88 112 118
Operating Profit 8 1 -1 2 1 1 2 2 5 4 1 -3 -3
OPM % 18% 2% -2% 2% 2% 2% 4% 4% 7% 5% 1% -3% -3%
1 1 12 4 0 2 1 2 1 1 2 2 1
Interest 3 2 2 1 1 1 1 2 1 2 2 2 3
Depreciation 1 2 1 1 2 4 4 3 3 3 3 3 3
Profit before tax 5 -2 8 3 -1 -2 -2 -1 2 0 -3 -7 -7
Tax % 46% -37% 50% 12% -15% -30% 0% -19% 0% 14% 8% 5%
4 0 4 3 -1 -1 -2 -1 2 0 -3 -7 -8
EPS in Rs 9.61 0.00 9.51 6.24 -2.34 -2.37 -3.65 -1.81 2.52 -0.34 -5.57 -13.97 -15.51
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 13%
3 Years: 15%
TTM: 25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -118%
Stock Price CAGR
10 Years: 1%
5 Years: 8%
3 Years: -7%
1 Year: -37%
Return on Equity
10 Years: -3%
5 Years: -3%
3 Years: -6%
Last Year: -13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 4 4 4 5 5 5 5 5 5 5
Reserves 36 36 41 43 41 50 54 58 58 58 55 47
13 9 7 7 10 14 15 12 12 11 11 14
21 26 17 28 28 25 28 32 35 38 43 59
Total Liabilities 73 75 69 82 83 94 102 107 110 112 114 125
14 12 13 18 18 26 26 24 23 19 18 17
CWIP 1 1 1 1 0 0 0 1 3 4 4 4
Investments 15 16 10 3 0 1 1 2 2 2 2 2
44 46 46 60 64 68 75 80 82 87 91 102
Total Assets 73 75 69 82 83 94 102 107 110 112 114 125

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
6 7 -11 -3 -3 4 3 7 5 -3 4 -3
-2 -0 15 4 1 -10 -4 -17 -4 1 -2 3
-5 -6 -3 -1 1 13 4 3 -2 -2 -2 1
Net Cash Flow -0 1 0 -1 0 7 4 -7 -0 -4 1 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 185 191 143 118 129 150 155 125 100 134 117 85
Inventory Days 345 424 285 225 223 289 301 349 307 298 245 250
Days Payable 163 343 156 169 168 217 234 234 208 183 202 195
Cash Conversion Cycle 367 271 272 174 184 222 223 239 199 249 160 141
Working Capital Days 101 97 156 111 115 110 110 117 105 135 97 78
ROCE % 14% -0% -1% 3% 0% -2% -1% 3% 4% 2% -1% -6%

Shareholding Pattern

Numbers in percentages

6 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
59.16% 59.09% 59.09% 59.18% 50.86% 50.88% 50.93% 50.95% 50.95% 50.98% 50.99% 51.06%
1.98% 1.98% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79%
38.86% 38.94% 39.13% 39.02% 47.36% 47.34% 47.28% 47.26% 47.28% 47.23% 47.23% 47.16%
No. of Shareholders 1,4431,6381,9332,0302,1152,2332,3702,6902,5102,5392,5382,550

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings